Ambys Medicines and Takeda Announce Partnership to Pioneer First-in-Class Therapies for the Treatment of Serious Liver Diseases
pharmaceutical-investing Phase 3 Trial of NINLARO (ixazomib) as Maintenance Therapy Met Primary Endpoint
pharmaceutical-investing Takeda and TiGenix Announce Results of Second Acceptance Period for the Voluntary and Conditional Public Takeover Bid
pharmaceutical-investing Takeda and TiGenix Announce Results of First Acceptance Period for the Voluntary and Conditional Public Takeover Bid of TiGenix
